Investors :: Carrick Therapeutics Limited

Latest News

View all news

Feb 14, 2024

Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer

Read more

Dec 15, 2023

Carrick Therapeutics Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib in Combination with Fulvestrant in Patients with Advanced HR+, HER2- Breast Cancer

Read more

Oct 18, 2023

Carrick Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Samuraciclib in Combination with Elacestrant in Patients with Advanced Breast Cancer

Read more

View all news

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

IR Contacts

Headquarters

Carrick Therapeutics Limited

T: +353 1 5996873
hello@carricktherapeutics.com